Randomised trial of hyperimmune immunoglobulin in hospitalised COVID-19: pre-therapy Fc receptor ...
November 15, 2026
Share
Randomised trial of hyperimmune immunoglobulin in hospitalised COVID-19: pre-therapy Fc receptor binding SARS-CoV-2 antibody associated with better outcomes.